Related references
Note: Only part of the references are listed.Immunohistochemical detection of PD-L1 among diverse human neoplasms in a reference laboratory: observations based upon 62,896 cases
Dennis P. O'Malley et al.
MODERN PATHOLOGY (2019)
Nuclear localization of PD-L1: artifact or reality?
Hara Polioudaki et al.
CELLULAR ONCOLOGY (2019)
Elevated PD-L1 expression predicts poor survival outcomes in patients with cervical cancer
Xiaobin Gu et al.
CANCER CELL INTERNATIONAL (2019)
The prognostic significance of PD-L1 and PD-1 expression in patients with nasopharyngeal carcinoma: a systematic review and meta-analysis
Zi-Lu Huang et al.
CANCER CELL INTERNATIONAL (2019)
Prognostic Implications of PD-L1 Expression in Breast Cancer: Systematic Review and Meta-analysis of Immunohistochemistry and Pooled Analysis of Transcriptomic Data
Alexios Matikas et al.
CLINICAL CANCER RESEARCH (2019)
Immune checkpoint inhibitors of PD-L1 as cancer therapeutics
Akintunde Akinleye et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Therapeutic Monoclonal Antibodies Targeting Immune Checkpoints for the Treatment of Solid Tumors
Nicholas Gravbrot et al.
ANTIBODIES (2019)
Tumor cells versus host immune cells: whose PD-L1 contributes to PD-1/PD-L1 blockade mediated cancer immunotherapy?
Fei Tang et al.
CELL AND BIOSCIENCE (2018)
Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, efficacy, and Limitations
Judith A. Seidel et al.
FRONTIERS IN ONCOLOGY (2018)
Immune regulation of metastasis: mechanistic insights and therapeutic opportunities
Olga S. Blomberg et al.
DISEASE MODELS & MECHANISMS (2018)
Programmed death ligand 1 is expressed in canine B cell lymphoma and downregulated by MEK inhibitors
S. R. Kumar et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2017)
Prognostic Significance of Canine Mammary Tumor Histologic Subtypes: An Observational Cohort Study of 229 Cases
Roberta Rasotto et al.
VETERINARY PATHOLOGY (2017)
A canine chimeric monoclonal antibody targeting PD-L1 and its clinical efficacy in canine oral malignant melanoma or undifferentiated sarcoma
Naoya Maekawa et al.
SCIENTIFIC REPORTS (2017)
Targeting T Cell Co-receptors for Cancer Therapy
Margaret K. Callahan et al.
IMMUNITY (2016)
Increased programmed death ligand-1 expression predicts poor prognosis in hepatocellular carcinoma patients
Xiaobin Gu et al.
ONCOTARGETS AND THERAPY (2016)
Immunohistochemical Analysis of PD-L1 Expression in Canine Malignant Cancers and PD-1 Expression on Lymphocytes in Canine Oral Melanoma
Naoya Maekawa et al.
PLOS ONE (2016)
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Suzanne L. Topalian et al.
CANCER CELL (2015)
Cytotoxic T lymphocyte antigen 4 expression in human breast cancer: implications for prognosis
Haiming Yu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Author's response to Letter to the editor: unvalidated antibodies and misleading results
S. Muenst et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Comparative analysis of innate immune system function in metastatic breast, colorectal, and prostate cancer patients with circulating tumor cells
Mark F. Santos et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2014)
Influence of PD-L1 cross-linking on cell death in PD-L1-expressing cell lines and bovine lymphocytes
Ryoyo Ikebuchi et al.
IMMUNOLOGY (2014)
New inhibitory signaling by CTLA-4
Christoph Wuelfing et al.
NATURE IMMUNOLOGY (2014)
Expression of PD-L1 on Canine Tumor Cells and Enhancement of IFN-γ Production from Tumor-Infiltrating Cells by PD-L1 Blockade
Naoya Maekawa et al.
PLOS ONE (2014)
Identification of prognostic factors in canine mammary malignant tumours: a multivariable survival study
Andreia A. Santos et al.
BMC VETERINARY RESEARCH (2013)
Circulating tumor cells (CTCs) from metastatic breast cancer patients linked to decreased immune function and response to treatment
Taryn L. Green et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2013)
Prognostic Value of Histological Grading in Noninflammatory Canine Mammary Carcinomas in a Prospective Study With Two-Year Follow-Up: Relationship With Clinical and Histological Characteristics
L. Pena et al.
VETERINARY PATHOLOGY (2013)
Evaluation of CTLA-4 expression and relevance as a novel prognostic factor in patients with non-small cell lung cancer
Sandra Salvi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Molecular cloning and expression analysis of the canine chemokine receptor CCR9
Shingo Maeda et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2012)
Classification and Grading of Canine Mammary Tumors
M. Goldschmidt et al.
VETERINARY PATHOLOGY (2011)
Structure and function of programmed death (PD) molecules
A. Folk et al.
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY (2010)
Evaluation of hormone receptor expression for use in predicting survival of female dogs with malignant mammary gland tumors
Chao-Chin Chang et al.
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION (2009)
PD-1 and its ligands in tolerance and immunity
Mary E. Keir et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
Mammary tumor recurrence in bitches after regional mastectomy
Nina Stratmann et al.
VETERINARY SURGERY (2008)
Overexpression of B7-H1 (PD-L1) significantly associates with tumor grade and postoperative prognosis in human urothelial cancers
Juro Nakanishi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Development and evaluation of canine reference genes for accurate quantification of gene expression
Bas Brinkhof et al.
ANALYTICAL BIOCHEMISTRY (2006)
Prognostic factors associated with survival two years after surgery in dogs with malignant mammary tumors: 79 cases (1998-2002)
SC Chang et al.
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION (2005)
Histological grading and prognosis in dogs with mammary carcinomas: Application of a human grading method
M Karayannopoulou et al.
JOURNAL OF COMPARATIVE PATHOLOGY (2005)
X-tile: A new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization
RL Camp et al.
CLINICAL CANCER RESEARCH (2004)
Share Paper
